• Sustainable investing saw record increases despite overall market downturn in Q1 2020
• ESG ratings take into account environmental, social and governance factors of interest to investors
• SGTM operates with mission to serve, protect environment while providing synergistic solutions to waste disposal problems
• SGTM Q2 2020 results include over $12.3 million in revenue, $3.4 million in gross profit, nearly doubled from Q1

Investment markets post-COVID-19 saw record first-quarter inflows to sustainable funds that take environmental, social and governance (“ESG”) ratings into account, along with traditional financial metrics (http://ibn.fm/2EG5j). Sustainable Green Team (OTC: SGTM), a leading provider of environmentally-beneficial solutions for tree and storm waste disposal, experienced impressive gains alongside this market shift through a surge in its activities that transform natural waste into useful organic products that benefit the environment

Environmental, social and governance factors are increasing in importance among investors—particularly those focused on issues concerning environmental waste, climate change, resource scarcity, labor practices and product safety. Despite recent market turmoil and extreme price volatility, many ESG-focused funds have outperformed the broader market this year (http://ibn.fm/GQQK2), suggesting an overall change in sentiment among investors that prioritize ESG issues as a part of their investment strategy. SGTM is among those companies that takes ESG factors seriously, making environmental stewardship central to its operations.

“At the end of the day it’s important to share that belief that we are stewards of the environment, and that shouldn’t be understated,” said SGTM CEO Tony Raynor in a recent interview (http://ibn.fm/aQNji). “We really enjoy it, and we’re passionate about what we do.”

Formerly known as National Storm Recovery Inc., SGTM provides synergistic and environmentally beneficial solutions to tree and storm waste disposal that would otherwise create an environmental burden on landfills and disposal sites throughout the United States. Through its subsidiaries, the company provides tree services, debris hauling, and waste removal in its overall effort to transform organic waste into products such as mulch and playground surface material. The company recently announced its impressive Q2 results that include over $12.3 million in revenue and $3.4 million in gross profit (http://ibn.fm/GhZC9) – almost double its Q1 results of $6.2 million and $1.7 million, respectively (http://ibn.fm/iiwQT).

STGM’s explosive growth can be attributed to several factors in line with its corporate strategy that is focused on expansion, investment and revenue stream diversification. The company recently acquired Mulch Manufacturing Inc., a 35-year-old industry leader and innovator in mulch manufacturing that significantly expanded SGTM’s footprint through its established networks in sales, distribution and production. Along with the acquisition were significant corporate investments that included the purchase of grapple hauling trucks and construction upgrades to its waste management landfill facility, enabling the company to increase production of its organic next-generation mulch products and playground surface material.

With a focus on ESG principles, SGTM takes its mission of protecting and serving the environment seriously, providing solutions for tree and storm waste disposal that otherwise would have created a burden on local landfills and waste disposal sites. Despite the current economic environment, SGTM continues to grow as demand for its services increases among its wide range of public and private-sector clients.

To learn more about Sustainable Green Team Ltd., view the investor presentation at http://ibn.fm/jvrhi.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Company focused on furthering R&D of psilocybin-based medications
• Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain
• Psilocybin shows promise for an array of mental health issues

Cybin Corp. is a leading life-science company focused on psychedelic and nutraceutical products to support various psychiatric and neurological conditions. The company is engaged in clinical trials, through a partnership with the Toronto Centre for Psychedelic Science (“TCPS”) to gain regulatory approval for psilocybin and other psychedelic products (http://ibn.fm/RgpQc).

In the 1940s, the study of psychedelic drugs for the treatment of mental health conditions began with the discovery of LSD. However, President Richard Nixon put a stop to this research in the 1960s with his war on drugs. Only recently have researchers began to explore psychedelics once again. This research is showing positive results in the treatment of depression, anxiety, PTSD, addictions, eating disorders, ADHD and more.

This evolution couldn’t be more timely. In the midst of a worldwide pandemic, the need for anxiety-reducing therapies has grown substantially, and psychedelics may have the potential to make a profound impact. Clinical studies for PTSD and psilocybin therapy for treatment-resistant depression has won the acknowledgment of the FDA (http://ibn.fm/V3HpZ). The combined cooperation of the FDA and investors is breaking down previous barriers. Psychedelic treatment may soon become mainstream.

Cybin believes that psychedelic substances derived from mushrooms can work as boosters for the brain, potentially rebuilding pathways and breaking negative patterns. Today more than 700 million people around the world struggle with mental illness, addiction or eating disorders — all areas where the benefits of psychedelic substances is being studied. What’s more, even though over 40 million Americans are taking psychiatric drugs, Big Pharma has not produced any new drug innovations in the last ten years (http://ibn.fm/yuVvc).

The world is changing quickly, and people are looking for new and improved options for managing their health. Right now, only 10% of fungi species are taxonomically classified, leaving an enormous potential for future medical research. Cybin is at the forefront of that research, paving the way for new advances and leveraging its expertise in the world of medicinal mushrooms.

Cybin operates in the functional-mushroom market with a goal to develop fungi-derived medicinal products to treat mental illness and other health conditions. The business model of this early-stage, life-sciences company includes two wholly owned core subsidiaries: Serenity Life Sciences, focusing on advancing research and development of psilocybin-based pharmaceutical products, and Natures Journey Inc., developing medicinal nonpsychedelic nutraceutical products.

For more information about this company, please visit www.Cybin.com.

NOTE TO INVESTORS: The latest news and updates relating to Cybin are available in the company’s newsroom at http://ibn.fm/Cybin

• SGMD, BudCars cannabis delivery service set to break sales, profits, customer orders records
• BudCars demonstrating “accelerating growth,’ represents significant period-over-period upside potential
• Company remains on track to reach $11 million benchmark for annualized sales by the close of calendar Q3

With August wrapping up, Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, expects the month-end numbers for BudCars Cannabis Delivery Service to set multiple performance records for sales, gross profits and total customer orders (http://ibn.fm/aLwaC).

“[The] BudCars Sacramento hub continues to demonstrate accelerating growth that suggests we still haven’t really found the ceiling here in terms of period-over-period upside potential,” said Sugarmade CEO Jimmy Chan. “Ultimately, this is gratifying to see because we have taken a unique approach to retail cannabis product distribution.”

Based on mid-July analysis and projections, BudCars appeared to be on a trajectory to meet or exceed previously identified goals of $650,000 in total sales and more than 5,000 individual customer orders for July; if met, those numbers continue an impressive streak of sequential month-over-month topline growth at or above the company’s target 30% level.

In addition, this consistent upward trends puts the company right in line to reach — or exceed — the $11 million benchmark for annualized sales by the close of calendar Q3, which the SGMD executive team announced previously in its updated guidance materials (http://ibn.fm/QOoIW).

Sugarmade is also on right on track with other strategic plants to leverage the current cannabis market needs. “We are pursuing three primary avenues to drive growth: organic execution, geographic expansion, and verticalization of our supply chain,” said Chan. “In each case, we continue to make progress. However, at this point, we have only scratched the surface of what is possible over the intermediate term for BudCars given that all of the growth we have booked so far has been exclusively about organic execution as we claim an increasing share of the market and drive enthusiastic repeat business from newly acquired customers.”

Specifically, SGMD has plans to launch new BudCars locations in the Los Angeles regional market and is pursuing the incorporation of in-house cultivation and cannabis product manufacturing at a new 5,000 square-foot, indoor, premium-cannabis cultivation facility located near its Sacramento BudCars hub.

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products, including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes CarryOutsupplies.com and SugarRush(TM).

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Company’s Standard Processing License pending approval from Health Canada
• After licensing approval, Pure Extracts will be launching white label production as part of core services
• Pure Extracts facility designed to produce high-quality, high-purity formulations on a commercial scale

Pure Extract Technologies, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is preparing to become a leading contender in the white labeling space. The Company’s Standard Processing License is currently pending approval from Health Canada; upon approval the Company will be launching white label production as part of its core services.

As an expert in the extraction field, Pure Extracts provides white label solutions based on custom formulating high-quality oils sourced from both cannabis and hemp-biomass products. In addition, the Company offers impressive expertise in designing and manufacturing consumer-ready packaging for customers.

White label products, which are products made by one company and then packaged and sold by other companies under various brand names, can provide substantial time, energy and financial savings in terms of production and marketing (http://ibn.fm/7KVnv). The practice has been steadily growing and often allows a company to offer quality products that they would otherwise be unable to provide.

As a leading extraction company, Pure Extracts is able to rapidly develop and commercialize extraction systems for plant-based medicine products. The Company has a centralized 10,000-square-foot facility built to EU-GMP standards and designed for proprietary and white label production; the facility is located in Pemberton, British Columbia. A phase 2 plan currently under development will expand the facility to 25,000 square feet and build it to EU-GMP standards, allowing the Pure Extracts to offer international distribution.

Designed with future growth in mind, the facility includes a dedicated lab that provides invaluable research and development services, is easily scalable, and offers modern CO2 and ethanol extraction capabilities and processes. The Company is designed to produce high-quality, high-purity formulations on a commercial scale.

In short, for companies licensed to sell specialized oil extracts and for CPG brands seeking licensed manufacturing partners, Pure Extracts offers a one-stop solution that ensures expert production and manufacturing resulting in top-quality products.

Pure Extracts is positioned to enter the commercial cannabis sector as an experienced producer. Led by a team of qualified experts in the space and providing cutting-edge CO2 and ethanol extraction technology, the Company is set up for long-term strategic distribution and product innovation.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

• SGTM receives approval to accept debris, manufacture mulch at state-of-the art Jacksonville facility
• Approval latest in notable list of milestones for expanding company
• After posting record Q2 revenue numbers, CEO predicts another positive quarter

In yet another significant moment for the growing company, Sustainable Green Team (OTC: SGTM) received permit approval to accept debris and manufacture mulch at its largest facility, located in Jacksonville (http://ibn.fm/hwtcU). SGTM is a leading provider of environmentally beneficial solutions for tree and storm waste disposal.

“Another major achievement for our team and shareholders,” said SGTM CEO and director Tony Raynor. “Not only does this approval allow us to expand our services, it allows us to open a retail mulch supply location for retail customers; the infrastructure is already in place. I look forward to sharing more about our new approved site as well as many other updates as they progress.”

SGTM’s state-of-the-art, 100,000-square-foot Jacksonville facility sits on 28 acres of concrete and is ideally structured for the company to continue to pursue the strategic expansion of its debris collection and grapple hauling services. Permit approval came from the Jacksonville City Council, which voted on the ordinance with no opposition.

Other milestones for the company this year have included the addition of new grapple hauling trucks to its fleet (http://ibn.fm/7T4nt); the construction completion of a dual-line mulch bagger and fully automated electric grinding screening operation at its Apopka, Florida, landfill facility (http://ibn.fm/2iHxk); and the diversification of revenue stream by receiving International Play Equipment Manufacturers Association (“IPEMA”) certification and approval to manufacture tree-waste material into playground surfacing material (http://ibn.fm/zLvSr).

In addition, SGTM released impressive figures for Q2 2020, recording $12,382,491 in revenue, $3,458,164 in gross profit, and $40,710,954 in total assets, with a strong position of $7,004,807 in cash and liquid investments (http://ibn.fm/B6Xmb).

“We are very pleased with our performance and direction,” said Raynor. “The positive recorded numbers were generated prior to achieving IPEMA certification for public surfacing material, which diversified our revenue stream; prior to construction at our Waste Management landfill facility, which further increased mulch manufacturing; and prior to the addition of new grapple hauling trucks to our fleet, which increased efficiency and production. The subsequent events look to lead us to another positive quarter, and we look forward to seeing how it all unfolds.”

Sustainable Green Team, through its subsidiaries, including National Storm Recovery LLC (DBA Central Florida Arbor Care and Mulch Manufacturing Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

To learn more about Sustainable Green Team Ltd., view the company’s investor presentation at http://ibn.fm/N785O

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Pharmaceutical supplies and services innovator Trxade Group Inc. has announced a new B2B resource that bundles telemedicine services that may prove particularly useful for companies during the ongoing pandemic period
• Trxade Group’s new Bonum+ platform combines the power of telehealth consultation, AI-driven COVID-19 risk assessment and streamlined personal protective equipment purchasing to help manage employees’ care and performance
• The company is an emerging web-based presence in the wellness market that builds trust and independent pharmacy purchasing power through drug pricing transparency
• The company has achieved more than 50 percent penetration among the nation’s approximately 22,000 independent pharmacies.

Trxade Group (NASDAQ: MEDS) is expanding the B2B functionality of its supply chain trading platform through a first-of-its-kind bundled service that combines telehealth performance, a COVID-19 risk assessment tool and a personal protective equipment (“PPE”) purchasing tool to help businesses better deal with the medical needs of their internal corporate structures during an era of pandemic and beyond.

The company’s Bonum+ platform (http://ibn.fm/AAgH9) builds on the Bonum Health Hub wellness brand that has established a web-accessible medical consultation service in conjunction with an online prescription pharmaceutical presence (http://ibn.fm/D0N1Y) and the company’s app-accessible DelivMeds same-day / mail order pharmaceuticals delivery service (http://ibn.fm/wnW0S).

“This platform resolves a fundamental trust problem impacting employer’s safety and security policies, allowing companies to more effectively combat COVID-19 concerns in the workplace,” Bonum Health President Ashton Maaraba stated in the company’s most recent announcement. “Looking forward, we plan to continue to expand the breadth of services offered by Bonum Health, including adding a digital health hub with next-generation prescription concierge services.”

The Bonum+ platform centralizes communication and provides tools for COVID-19 contact tracing that helps companies assess employee risk profiles and respond as necessary with new PPE resources. The platform also offers health recommendations and connects employees with board certified physicians when needed, utilizing integrated artificial intelligence to streamline processes.

Trxade Group has distinguished itself as a web-based presence in the wellness market that emphasizes transparency in the pharmaceutical purchasing pipeline, empowering subscribers to assess drug prices and supply availability to make best product ordering decisions.

The company’s flagship platform has achieved more than 50 percent market penetration in attracting nearly 12,000 of the United States’ estimated 22,000 independent pharmacies so far, helping them to become more competitive with large pharmaceutical retail chains.

“Our platform lets these independents know that they’re receiving a fair price from competing suppliers on fair payment terms and often with next day delivery,” Founder, Chairman and CEO Suren Ajjarapu said in a recent earnings conference call (http://ibn.fm/HDLeo). “We believe this radical price transparency, economy of scale and competition amongst suppliers leads (to) up to 10% reduction in pharmacies’ total annual drug purchase costs, with a drug-level savings of up to 90% on certain pharmaceutical products.”

Trxade Group thereby saves pharmacists from labor-intensive cost comparisons between pharmaceutical distributors on a repetitive basis, profiting through a fee structure similar in nature to the ones employed by merchandising pioneers such as PayPal and Visa.

The company’s second quarter financial report notes that revenues increased 244 percent year-over-year for the quarter, and by 199 percent sequentially from the first quarter of the year.

“We believe that we are well positioned to execute upon the immense opportunity facing us today, supporting critical public health efforts nationwide,” Maaraba stated.

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

• Recent investment article notes ISWH’s financial report shows “larger than forecast topline growth.”
• The report represents the fifth consecutive quarter of strong growth by ISWH.
• Strong forecast based on strong performance by company’s home health division, cryptocurrency mining joint venture.

The recent Q2 ISW Holdings (OTC: ISWH) financial report (http://ibn.fm/AwEC6), which included operational performance data for the three months and six months ended June 30, 2020, “silence(d) the skeptics, with larger than forecast topline growth powered by an expanding home healthcare segment, which could be set to further advance as the company integrates its proprietary telehealth technology into the mix,” noted a recent “Oracle Dispatch” article (http://ibn.fm/OUXlm).

The report represents the fifth consecutive quarter of strong growth by ISWH, a brand-management portfolio company with a growing home health division. “According to the company’s release, revenues for the three months ended June 30 totaled $248,675, and $485,593 for six months ended June 30, representing year-over-year growth of 79% (and 244%) compared to comparable periods in 2019,” the article continued. “Gross profits for the three months ended June 30 totaled $94,692, and $134,011 for the six months ended June 30, representing year-over-year growth of 72% (and 152%) compared to comparable periods in 2019.”

Contributing to the company’s consistently strong bottom line and bright forecast is the strong performance turned in by the company’s home health division, Paradigm Home Health (“PPH”), as well as the joint venture ISWH operates with Bit5ive, a global leader in cryptocurrency mining.

“We demonstrated the continued viability of our Home Healthcare business during a tumultuous quarter beset by tremendous challenges across the country due to the pandemic health crisis,” said ISW Holdings president and chairman Alonzo Pierce. “We also set the stage for accelerating growth in the back half of the year as we look forward to continued developments in both our telehealth and crypto mining endeavors at a time when the context is very promising in both of those markets. We have shown strong topline growth now for five consecutive quarters almost solely driven by PHH. We feel we are well positioned to continue that growth and begin to see tangible returns from our crypto mining investments over coming months as well.”

Based in Nevada, ISW Holdings is a diversified portfolio company comprised of essential business lines that serve consumer product demands. The company’s expertise lies in strategic brand development and early-growth facilitation, as well as brand identity through its proprietary procurement process. Together with its partners, ISWH seeks to provide a structure that meets large scalability demands as well as anticipated marketplace needs. ISWH maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

For more information about ISW Holdings, please visit the company’s website at www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

• Company predicts BudCars will reach $650,000 monthly sales milestone; Q3 2020 numbers to top $11 million
• CEO expects extremely robust growth in July, August; new records across many metrics
• BudCars has seen steady improvement in almost every major metric

Sugarmade Inc. (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, has announced that it expects BudCars Cannabis Delivery Service to hit a $650,000 sales milestone in July (http://ibn.fm/LDXLJ). The company also predicts its Q3 2020 sales numbers will top $11 million.

“We believe we have enough visibility and enough data in hand to forecast that we will continue to see extremely robust growth in July and August,” stated Sugarmade CEO Jimmy Chan. “Many of the trends we saw come together in June to drive our performance remain in place and suggest new records across many metrics are likely this month as well.”

The strong numbers are based on SGMD’s impressive growth and underlying data trends in May and June, along with even stronger numbers for the first part of July. Using the current figures as a baseline, the Sugarmade team is anticipating continued strong month-over-month sales growth of 30% in July and August, which would bring the company to $650K in July and on pace to close out September with annualized BudCars revenues reaching $11 million.

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products, including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

BudCars has reported constant improvement in almost every major metric — from increasing new customers and increasing orders per customer to strong repeat business — since Sugarmade invested in the company earlier this year. This steady growth provides a high degree of confidence in the company’s forecast of continued 30% sequential monthly topline growth and the likelihood that SGMD will close out Q3 2020 with an extremely strong performance heading into year-end.

In addition, Sugarmade continues to focus on further strengthening future top and bottom-line growth through strategic expansion and verticalization plans. The company has already announced the opening of its second BudCars hub in Los Angeles, as well as the establishment of in-house cultivation and product manufacturing operations at its new 5,000 square-foot, indoor, premium-cannabis cultivation facility located near its Sacramento BudCars hub.

Sugarmade Inc. is a product and branding marketing company investing in operations and technologies with disruptive potential. In addition to its financial interest in the BudCars brand, SGMD’s brand portfolio includes CarryOutsupplies.com and SugarRush(TM).

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• POAI, Helomics builds AI-driven models that predict drug response, patient outcome
• Company tests patient tumor, generates comprehensive picture that oncologists use to individualize therapy
• Key to individualized insight is POAI’s Tumor Drug Response Profiling (“TDRP”) platform, NGS-based genomic profiling, unmatched cancer knowledge base

Guided by the mantra that “cancer is personal — we believe therapy should be too,” Predictive Oncology (NASDAQ: POAI) subsidiary Helomics focus on building AI-driven models that will predict drug response and patient outcome of individual tumors. With the largest tumor inventory in the world, POAI leads the way in providing a functional precision medicine approach that harnesses the power of an individual patient’s tumor to personalize their cancer treatment plan.

POAI works closely with oncologists to provide key information to help improve their patients’ odds in their fight against cancer. Helomics current clinical test platform offers a powerful, proprietary approach that tests a patient’s unique tumor, then combines drug-response profiling and genomic profiling of that tumor to generate a comprehensive picture that an oncologist can use to individualize therapy and improve positive outcomes.

Oncologists rely on these personalized profiles to help reduce the risk that a patient receives ineffective therapies as well as to identify alternatives when a typical treatment recommended for certain types of cancer cannot be tolerated.

A key component in Predictive Oncology’s ability to offer such individualized insight is the company’s Tumor Drug Response Profiling (“TDRP”) platform, which it combines with the latest NGS-based genomic profiling and POAI’s vast cancer knowledge-base of 150,000 tumors. Exclusive to POAI, these resources provide a more functional approach to precision medicine and allow an oncologist to reach beyond genomics alone in providing cancer-treatment recommendations.

In addition, every tumor tested by POAI and Helomics adds data to the company’s unparalleled D-CHIP knowledgebase, which contains anonymized molecular and drug-response profiles from more than 150,000 cancer cases. This invaluable information provides researchers in pharma, biopharma and diagnostic companies actionable insights to help discover better targeted therapies as well as contribute to key developments in clinical trials, companion diagnostics, and biomarkers.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through the company’s Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy. In addition, the company is utilizing artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow

For more information about the company, visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Gold continues to post record highs despite recent volatility
• Gold price broke previous 2011 ceiling of $1921 per ounce
• KGS plans to increase gold production at historic gold mining sites using new technologies
• KGS entered into option agreements to obtain 100% ownership of the Mohave Project in Arizona and Cadillac East Property in Quebec, Canada

Despite negative headlines focused on recent price drops (http://ibn.fm/XCUAS), the price of gold continues to set record highs, eclipsing the effects of recent volatility. Kingman Minerals (TSX.V: KGS), a Canada-based mining company focused on the acquisition, exploration and development of gold and silver properties in North America, is planning to increase gold production in anticipation of rising prices by sourcing and developing historic mining sites for new drilling campaigns that extract the remaining wealth using innovative, safe and cost-effective technology.

The price of gold recently took a “plunge” according to experts at Forbes closing at nearly $1,900 at the time of printing. While the noted drop in the price was substantial, this level is still among the highest seen so far in 2020, and not far off from its record high of $1,921 last seen in 2011 (http://ibn.fm/um1oP). While stock markets may be experiencing extreme volatility as a result of recent economic events, the value of gold continues to endure, prompting investors to keep shifting capital into “safe haven” assets like precious metals as a measure to protect the value of their wealth amid fears of inflation, overvalued stocks and other events upending the global economy.

KGS anticipated the rising trend of gold prices long before they reached this critical point, sourcing historic mining sites throughout North America as part of its production strategy aimed at extracting the remaining gold left behind by previous generations through the use of modern technology. Two notable properties of interest include the Cadillac East Property in Quebec, Canada and the Mohave Project located in Arizona – both offering potential for the profitable production of gold, positioning KGS favorably to investors looking for stable assets that can withstand short-term price volatility.

The Cadillac East Property is located approximately 55 kilometers east of Val d’Or, a key mining and exploration hub located in Quebec, Canada. Following extensive geophysical and geological surveys, KGS recently acquired an interest in the property from an arm’s length vendor with an option agreement to earn 100% over three years. Besides its 12 lode claims, the area was also identified by Exploration Facilitation Unlimited Inc. in 2017 as having potential value in other metals that include silver, copper, zinc and nickel (http://ibn.fm/Dvp8B).

The Mohave Project, another key property in KGS’s portfolio, comprises 20 lode claims that include the historic 167-hectare Rosebud Mine. Originally discovered in the 1880s, some wealth remains, according to studies conducted in the 1980s that estimated 664,000 ounces of gold and 2,600,000 ounces of silver. The company has recently completed two underground reconnaissance and sampling programs and is in the process of verifying these estimates by commissioning a report to be completed by Burgex Inc. (http://ibn.fm/49jNP), a consulting services company that specializes in the analysis of abandoned mining sites throughout the western United States.

Based in Canada, KGS is poised to benefit from current economic conditions through its strategy of developing a diverse portfolio of high-quality, lifelong mining assets. Through its strategy focused on exploring, acquiring and developing gold and silver properties in North America, the company continues to provide value to shareholders looking to diversify their portfolios with safe investments of enduring value.

For more information, visit the company’s website at www.KingmanMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS